Pneumocystis pneumonia associated with infliximab in Japan

N Engl J Med. 2007 Nov 1;357(18):1874-6. doi: 10.1056/NEJMc070728.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Case-Control Studies
  • Humans
  • Infliximab
  • Japan
  • Middle Aged
  • Pneumonia, Pneumocystis / chemically induced*
  • Product Surveillance, Postmarketing
  • Proportional Hazards Models
  • Risk Factors
  • Tumor Necrosis Factor-alpha / immunology*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab